Seres amends Cambridge lease: surrenders 14,760 sq ft, extends 68,636 sq ft to Jan 2030

Seres Therapeutics, Inc.

Surrenders 14,760 rentable sq ft of office/lab space effective Nov 12, 2023.
Extends lease on remaining 68,636 sq ft to Jan 13, 2030; initial rent $122/sq ft/yr with 3% annual escalations.
Receives 2-month free rent at start of extension and $1.72M tenant improvement allowance ($25/sq ft).
Rentable area after surrender: 68,636 sq ft; tenant's pro rata share in building becomes 36.39%.

item 1.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Seres Therapeutics, Inc. amended First Amendment to Lease with BMR-Sidney Research Campus LLC (effective 2022-12-09).

Action: amendment
Agreement: lease
Counterparty: BMR-Sidney Research Campus LLC
Effective: 2022-12-09

Exact text from the filing

On December 9, 2022, Seres Therapeutics, Inc. (the “Company”) entered into the First Amendment to Lease (the “First Amendment”) with BMR-Sidney Research Campus LLC (f/k/a BMR 200-Sidney Street LLC), a Delaware limited liability company (the “Landlord”), which amends the Lease Agreement, dated November 11, 2015

View on SEC.gov

Browse all material agreements →

Seres Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-304803

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.